World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as pf Jan-05-2024.

World Top Biopharmaceutical Companies 2024
World Largest Biopharmaceutical Companies by Market Cap in 2024, World Top Biopharmaceutical Companies by Market Cap in 2024.

  1. Cassava Sciences

    World Rank (Jan-05-2024)
    8,571
    Market Cap (Jan-05-2024)
    1.001 Billion USD
    World Rank (Jul-30-2023)
    9,406
    Market Cap (Jul-30-2023)
    0.876 Billion USD
    World Rank (Dec-25-2022)
    7,118
    Market Cap (Dec-25-2022)
    1.322 Billion USD
    World Rank (Jan-07-2022)
    6,450
    Market Cap (Jan-07-2022)
    1.92 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -76 Million USD
    Annual Net Income in USD
    -76 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile
    Cassava Sciences is a clinical stage biopharmaceutical company focused on neuroscience. The headquarters is in USA.
    Company Website
    CASSAVA SCIENCES

  2. CureVac

    World Rank (Jan-05-2024)
    8,888
    Market Cap (Jan-05-2024)
    0.945 Billion USD
    World Rank (Jul-30-2023)
    5,858
    Market Cap (Jul-30-2023)
    1.945 Billion USD
    World Rank (Dec-25-2022)
    7,544
    Market Cap (Dec-25-2022)
    1.197 Billion USD
    World Rank (Jan-07-2022)
    2,943
    Market Cap (Jan-07-2022)
    5.74 Billion USD
    Annual Revenue in USD
    74 Million USD
    Annual Operating Income in USD
    -276 Million USD
    Annual Net Income in USD
    -275 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Germany
    Yahoo @ Nasdaq
    Company Profile

    CureVac is the leading global Clinical Stage Biopharmaceutical company focused on the development of a completely new class of drugs based on the messenger RNA (mRNA). The headquarters is in Germany.

    Company Website
    CUREVAC
    Wikipedia
    Wikipedia

  3. 4D Molecular Therapeutics Inc.

    World Rank (Jan-05-2024)
    9,373
    Market Cap (Jan-05-2024)
    0.862 Billion USD
    World Rank (Jul-30-2023)
    10,151
    Market Cap (Jul-30-2023)
    0.768 Billion USD
    World Rank (Dec-25-2022)
    10,358
    Market Cap (Dec-25-2022)
    0.699 Billion USD
    World Rank (Jan-07-2022)
    12,298
    Market Cap (Jan-07-2022)
    0.60 Billion USD
    Annual Revenue in USD
    3 Million USD
    Annual Operating Income in USD
    -110 Million USD
    Annual Net Income in USD
    -107 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Company Profile
    4D Molecular Therapeutics is an Innovative Gene Therapy company designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions. The company annual revenue is 6.99 million USD and 78 employees as on 2019. The headquarters is in USA.
    Company Website
    4D MOLECULAR THERAPEUTICS INC.

  4. Pharma Mar

    World Rank (Jan-05-2024)
    9,684
    Market Cap (Jan-05-2024)
    0.816 Billion USD
    World Rank (Jul-30-2023)
    10,987
    Market Cap (Jul-30-2023)
    0.662 Billion USD
    World Rank (Dec-25-2022)
    7,221
    Market Cap (Dec-25-2022)
    1.288 Billion USD
    World Rank (Jan-07-2022)
    8,857
    Market Cap (Jan-07-2022)
    1.11 Billion USD
    Annual Revenue in USD
    229 Million USD
    Annual Net Income in USD
    92 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Spain
    Yahoo @ Spain
    Company Profile
    Pharma Mar is a biopharmaceutical company focused on anti cancer drugs based on marine invertebrates. The company annual revenue is 269.9 million EUR, annual operating income is 155.9 million EUR, annual net income is 137.2 million EUR and total assets are 330 million EUR as on 2020. The headquarters is in Spain.
    Company Website
    PHARMA MAR

  5. Avidity Biosciences Inc.

    World Rank (Jan-05-2024)
    9,931
    Market Cap (Jan-05-2024)
    0.779 Billion USD
    World Rank (Jul-30-2023)
    11,019
    Market Cap (Jul-30-2023)
    0.659 Billion USD
    World Rank (Dec-25-2022)
    6,880
    Market Cap (Dec-25-2022)
    1.389 Billion USD
    World Rank (Jan-07-2022)
    10,012
    Market Cap (Jan-07-2022)
    0.90 Billion USD
    Annual Revenue in USD
    9 Million USD
    Annual Operating Income in USD
    -178 Million USD
    Annual Net Income in USD
    -173 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Avidity Biosciences is a BioTechnology company and pioneer in new class of Oligonucleotide Based Therapies company designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. The company annual revenue is 5.3 million USD and 38 employees as on 2020. The headquarters is in USA.
    Company Website
    AVIDITY BIOSCIENCES, INC.

  6. Retrophin

    World Rank (Jan-05-2024)
    10,171
    World Rank (Jul-30-2023)
    10,171
    World Rank (Dec-25-2022)
    10,171
    World Rank (Jan-07-2022)
    10,171
    Headquarters Country
    USA
    Company Profile
    Retrophin is a is a Biopharmaceutical company whose mission is to identify, develop and deliver life changing therapies to people living with rare disease. The company annual revenue is 185.3 million USD and 221 employees as on 2020. The headquarters is in USA.
    Company Website
    RETROPHIN

  7. HilleVax Inc.

    World Rank (Jan-05-2024)
    10,227
    Market Cap (Jan-05-2024)
    0.741 Billion USD
    World Rank (Jul-30-2023)
    11,530
    Market Cap (Jul-30-2023)
    0.606 Billion USD
    World Rank (Dec-25-2022)
    12,802
    Market Cap (Dec-25-2022)
    0.470 Billion USD
    World Rank (Jan-07-2022)
    15,661
    Headquarters Country
    USA
    Company Profile
    HilleVax, Inc is a biopharmaceutical company focused on the development and commercialization of novel vaccines. The headquarters is in United States.
    Company Website
    HILLEVAX, INC.

  8. Olema Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    10,291
    Market Cap (Jan-05-2024)
    0.733 Billion USD
    World Rank (Jul-30-2023)
    15,099
    Market Cap (Jul-30-2023)
    0.343 Billion USD
    World Rank (Dec-25-2022)
    21,255
    Market Cap (Dec-25-2022)
    0.107 Billion USD
    World Rank (Jan-07-2022)
    16,820
    Market Cap (Jan-07-2022)
    0.29 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -24 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Olema Pharmaceuticals is a Clinical Stage Biopharmaceutical company. It is committed to the discovery, development and commercialization of a transformational generation of targeted therapies for women’s cancers. The headquarters is in USA.
    Company Website
    OLEMA PHARMACEUTICALS, INC.

  9. Stemline Therapeutics

    World Rank (Jan-05-2024)
    10,696
    World Rank (Jul-30-2023)
    10,696
    World Rank (Dec-25-2022)
    10,696
    World Rank (Jan-07-2022)
    10,696
    Headquarters Country
    USA
    Company Profile

    Menarini Group Completes acquired Stemline Therapeutics in June 2020.

    Stemline Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. ELZONRIS (tagraxofusp), a targeted therapy directed to CD123, is FDA-approved and commercially available in the U.S. for the treatment of adult and pediatric patients, two years and older, with blastic plasmacytoid dendritic cell neoplasm (BPDCN).

  10. Gracell Biotechnologies Inc.

    World Rank (Jan-05-2024)
    10,757
    Market Cap (Jan-05-2024)
    0.679 Billion USD
    World Rank (Jul-30-2023)
    16,436
    Market Cap (Jul-30-2023)
    0.271 Billion USD
    World Rank (Dec-25-2022)
    19,455
    Market Cap (Dec-25-2022)
    0.153 Billion USD
    World Rank (Jan-07-2022)
    16,212
    Market Cap (Jan-07-2022)
    0.32 Billion USD
    Headquarters Country
    China
    Company Website
    GRACELL BIOTECHNOLOGIES INC.

Share